Klcm Advisors, Inc. Pfizer Inc Transaction History

Klcm Advisors, Inc.

$792 Million
Q2 2024

A detailed history of Klcm Advisors, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Klcm Advisors, Inc. holds 128,672 shares of PFE stock, worth $3.74 Million. This represents 0.45% of its overall portfolio holdings.

Number of Shares

128,672

Previous 179,939 28.49%

Holding current value

$3.74 Million

Previous $4.99 Million 27.9%

% of portfolio

0.45%

Previous 0.66%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$25.26 - $29.6 $1.3 Million - $1.52 Million	-51,267 Reduced 28.49%	128,672 $3.6 Million
Q1 2024 May 16, 2024	BUY	$25.89 - $29.73 $159,119 - $182,720	6,146 Added 3.54%	179,939 $4.99 Million
Q4 2023 Jan 30, 2024	BUY	$26.13 - $33.94 $1.95 Million - $2.53 Million	74,487 Added 75.01%	173,793 $5 Million
Q3 2023 Nov 07, 2023	BUY	$32.09 - $37.51 $175,307 - $204,917	5,463 Added 5.82%	99,306 $3.29 Million
Q2 2023 Aug 08, 2023	SELL	$36.12 - $41.79 $121,796 - $140,915	-3,372 Reduced 3.47%	93,843 $3.44 Million
Q1 2023 May 11, 2023	BUY	$39.39 - $51.28 $2.51 Million - $3.27 Million	63,702 Added 190.08%	97,215 $3.97 Million
Q4 2022 Feb 10, 2023	BUY	$41.75 - $54.5 $162,365 - $211,950	3,889 Added 13.13%	33,513 $1.72 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $119,246 - $145,569	2,725 Added 10.13%	29,624 $1.3 Million
Q2 2022 Aug 04, 2022	SELL	$46.53 - $55.17 $78,821 - $93,457	-1,694 Reduced 5.92%	26,899 $1.41 Million
Q1 2022 May 03, 2022	SELL	$45.75 - $56.69 $7.33 Million - $9.08 Million	-160,172 Reduced 84.85%	28,593 $1.48 Million
Q4 2021 Jan 31, 2022	SELL	$41.32 - $61.25 $362,872 - $537,897	-8,782 Reduced 4.45%	188,765 $11.1 Million
Q3 2021 Nov 16, 2021	SELL	$39.25 - $50.42 $8.85 Million - $11.4 Million	-225,429 Reduced 53.3%	197,547 $8.5 Million
Q2 2021 Aug 03, 2021	SELL	$35.91 - $40.68 $1.58 Million - $1.78 Million	-43,878 Reduced 9.4%	422,976 $16.6 Million
Q1 2021 Apr 21, 2021	BUY	$33.49 - $37.77 $1.47 Million - $1.66 Million	43,871 Added 10.37%	466,854 $16.9 Million
Q4 2020 Jan 26, 2021	BUY	$33.47 - $42.56 $384,637 - $489,099	11,492 Added 2.79%	422,983 $15.6 Million
Q3 2020 Nov 03, 2020	SELL	$31.75 - $37.25 $779,176 - $914,152	-24,541 Reduced 5.63%	411,491 $15.1 Million
Q2 2020 Jul 27, 2020	SELL	$30.12 - $36.54 $977,273 - $1.19 Million	-32,446 Reduced 6.93%	436,032 $14.3 Million
Q1 2020 May 13, 2020	BUY	$27.03 - $38.62 $173,262 - $247,554	6,410 Added 1.39%	468,478 $15.3 Million
Q4 2019 Feb 04, 2020	BUY	$32.92 - $37.36 $468,780 - $532,006	14,240 Added 3.18%	462,068 $18.1 Million
Q3 2019 Nov 12, 2019	BUY	$32.49 - $42.13 $974,505 - $1.26 Million	29,994 Added 7.18%	447,828 $16.1 Million
Q3 2019 Nov 04, 2019	BUY	$32.49 - $42.13 $275,482 - $357,220	8,479 Added 2.07%	417,834 $15 Million
Q3 2019 Nov 04, 2019	BUY	$32.49 - $42.13 $1.29 Million - $1.68 Million	39,780 Added 10.76%	409,355 $14.7 Million
Q2 2019 Aug 15, 2019	BUY	$36.98 - $41.52 $122,810 - $137,887	3,321 Added 0.91%	369,575 $16 Million
Q1 2019 May 14, 2019	BUY	$37.5 - $41.2 $319,050 - $350,529	8,508 Added 2.38%	366,254 $15.6 Million
Q4 2018 Feb 14, 2019	SELL	$38.47 - $43.86 $227,588 - $259,475	-5,916 Reduced 1.63%	357,746 $15.6 Million
Q3 2018 Nov 14, 2018	SELL	$34.47 - $41.81 $756,995 - $918,189	-21,961 Reduced 5.69%	363,662 $16 Million
Q2 2018 Aug 09, 2018	BUY	$32.98 - $35.16 $161,371 - $172,037	4,893 Added 1.29%	385,623 $14 Million
Q1 2018 May 10, 2018	SELL	$31.91 - $37.02 $490,105 - $568,590	-15,359 Reduced 3.88%	380,730 $13.5 Million
Q4 2017 Feb 15, 2018	BUY	$33.26 - $35.29 $71,575 - $75,944	2,152 Added 0.55%	396,089 $14.3 Million
Q3 2017 Nov 14, 2017	SELL	$31.0 - $34.15 $362,359 - $399,179	-11,689 Reduced 2.88%	393,937 $14.1 Million
Q2 2017 Aug 15, 2017	BUY	N/A	405,626	405,626 $13.6 Million

Others Institutions Holding PFE

# of Institutions

3,220

Shares Held

3.71B

Call Options Held

73.2M

Put Options Held

108M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $163B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Klcm Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Klcm Advisors, Inc. with notifications on news.

Account

Klcm Advisors, Inc. Pfizer Inc Transaction History